Mirae Asset Global Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.1M | Buy |
145,188
+13,361
| +10% | +$1.12M | 0.02% | 398 |
|
|
2026
Q1 | $10.6M | Buy |
131,827
+22,078
| +20% | +$1.82M | ﹤0.01% | 386 |
|
|
2025
Q4 | $9.36M | Buy |
109,749
+23,514
| +27% | +$1.93M | 0.03% | 415 |
|
|
2025
Q3 | $6.71M | Buy |
86,235
+10,078
| +13% | +$787K | 0.02% | 459 |
|
|
2025
Q2 | $5.96M | Buy |
76,157
+8,144
| +12% | +$607K | 0.02% | 436 |
|
|
2025
Q1 | $4.82M | Buy |
68,013
+8,915
| +15% | +$638K | 0.02% | 459 |
|
|
2024
Q4 | $4.46M | Buy |
59,098
+12,149
| +26% | +$850K | 0.02% | 469 |
|
|
2024
Q3 | $3.13M | Sell |
46,949
-44,010
| -48% | -$3.2M | 0.01% | 511 |
|
|
2024
Q2 | $8.49M | Sell |
90,959
-128,134
| -58% | -$11.3M | 0.04% | 278 |
|
|
2024
Q1 | $18.8M | Buy |
219,093
+3,927
| +2% | +$330K | 0.04% | 418 |
|
|
2023
Q4 | $16.4M | Buy |
215,166
+3,923
| +2% | +$273K | 0.03% | 482 |
|
|
2023
Q3 | $14.6M | Sell |
211,243
-66,991
| -24% | -$5.38M | 0.03% | 494 |
|
|
2023
Q2 | $26.1M | Buy |
278,234
+69,740
| +33% | +$6.06M | 0.06% | 345 |
|
|
2023
Q1 | $17.2M | Buy |
208,494
+3,182
| +2% | +$250K | 0.04% | 441 |
|
|
2022
Q4 | $15.3M | Sell |
205,312
-21,857
| -10% | -$1.68M | 0.04% | 454 |
|
|
2022
Q3 | $18.8M | Sell |
227,169
-4,816
| -2% | -$463K | 0.05% | 375 |
|
|
2022
Q2 | $22M | Buy |
231,985
+12,862
| +6% | +$1.33M | 0.06% | 363 |
|
|
2022
Q1 | $25.8M | Sell |
219,123
-3,639
| -2% | -$408K | 0.05% | 363 |
|
|
2021
Q4 | $28.9M | Buy |
222,762
+15,992
| +8% | +$1.87M | 0.06% | 356 |
|
|
2021
Q3 | $23.4M | Sell |
206,770
-16,065
| -7% | -$1.83M | 0.06% | 377 |
|
|
2021
Q2 | $23.1M | Buy |
222,835
+114,082
| +105% | +$10.8M | 0.06% | 365 |
|
|
2021
Q1 | $9.1M | Sell |
108,753
-443,449
| -80% | -$37.5M | 0.03% | 554 |
|
|
2020
Q4 | $50.4M | Buy |
552,202
+246,388
| +81% | +$20.4M | 0.19% | 137 |
|
|
2020
Q3 | $24.4M | Buy |
305,814
+202,448
| +196% | +$15.8M | 0.12% | 190 |
|
|
2020
Q2 | $7.14M | Sell |
103,366
-35,255
| -25% | -$2.51M | 0.04% | 408 |
|
|
2020
Q1 | $8.72M | Buy |
138,621
+22,914
| +20% | +$1.65M | 0.07% | 306 |
|
|
2019
Q4 | $9M | Buy |
115,707
+10,491
| +10% | +$819K | 0.06% | 378 |
|
|
2019
Q3 | $7.71M | Buy |
105,216
+33,732
| +47% | +$2.37M | 0.05% | 379 |
|
|
2019
Q2 | $4.41M | Sell |
71,484
-9,483
| -12% | -$573K | 0.03% | 488 |
|
|
2019
Q1 | $5.14M | Buy |
80,967
+22,251
| +38% | +$1.27M | 0.04% | 407 |
|
|
2018
Q4 | $3M | Sell |
58,716
-588
| -1% | -$29.8K | 0.03% | 499 |
|
|
2018
Q3 | $3.43M | Buy |
59,304
+23,376
| +65% | +$1.14M | 0.03% | 511 |
|
|
2018
Q2 | $1.75M | Buy |
35,928
+13,239
| +58% | +$618K | 0.02% | 406 |
|
|
2018
Q1 | $1.06M | Buy |
22,689
+3,780
| +20% | +$164K | 0.01% | 492 |
|
|
2017
Q4 | $712K | Buy |
18,909
+2,829
| +18% | +$104K | 0.01% | 532 |
|
|
2017
Q3 | $585K | Sell |
16,080
-6,078
| -27% | -$232K | 0.01% | 515 |
|
|
2017
Q2 | $868K | Sell |
22,158
-25,077
| -53% | -$915K | 0.02% | 414 |
|
|
2017
Q1 | $1.48M | Buy |
47,235
+789
| +2% | +$24.7K | 0.03% | 323 |
|
|
2016
Q4 | $1.45M | Buy |
46,446
+11,586
| +33% | +$375K | 0.03% | 301 |
|
|
2016
Q3 | $1.4M | Sell |
34,860
-2,289
| -6% | -$86.2K | 0.03% | 281 |
|
|
2016
Q2 | $1.24M | Buy |
+37,149
| New | +$1.27M | 0.03% | 294 |
|
Other funds holding EW
WT
Mirae Asset Global Investments's EW Position: Q2 2026 in Review
Mirae Asset Global Investments increased its Edwards Lifesciences (EW) stake by 10% in Q2 2026, buying an estimated $1.12M and bringing the position to 145,188 shares worth $13.1M. The position accounts for 0.02% of the portfolio, ranked #398.
Mirae Asset Global Investments first reported a position in EW in Q2 2016 and has held it in 41 quarters since. The position peaked at $50.4M in Q4 2020. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Mirae Asset Global Investments held 145,188 shares of Edwards Lifesciences worth $13.1M as of Q2 2026.
- Mirae Asset Global Investments bought 13,361 Edwards Lifesciences shares in Q2 2026, an estimated $1.12M.
- Edwards Lifesciences made up 0.02% of Mirae Asset Global Investments's portfolio in Q2 2026, its #398 holding.
- Mirae Asset Global Investments first reported a position in Edwards Lifesciences in Q2 2016 and has held it in 41 quarters since.
- Mirae Asset Global Investments's Edwards Lifesciences position peaked at $50.4M in Q4 2020.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.